🏠 News Empire
health

India Mandates Prescriptions for High-Alcohol Medicinal Tinctures to Curb Misuse

Published on: 11 Jul 2026, 03:19 AM
India Mandates Prescriptions for High-Alcohol Medicinal Tinctures to Curb Misuse

The Indian government has announced that oral medicinal formulations containing more than 12% ethyl alcohol and sold in bottles larger than 30 ml will now require a doctor's prescription. The decision comes after complaints from states like Uttar Pradesh and Madhya Pradesh about the misuse of certain medicinal tinctures.

The Ministry of Health and Family Welfare has amended the Drugs Rules through the Drugs (Tenth Amendment) Rules, 2026. The products affected include herbal and medicinal liquid preparations such as cardamom and ginger tinctures. These are concentrated herbal extracts made using ethyl alcohol as a solvent and have traditionally been used as digestive aids. However, some formulations contain 60-80% ethyl alcohol, making them susceptible to misuse for intoxication.

Under the new rules, these formulations will no longer be exempt under Schedule K of the Drugs Rules, 1945. Instead, they will be classified under Schedule H1, which mandates sale only against a prescription from a registered medical practitioner. Pharmacies must also maintain records of every sale. The rules will come into effect six months after their publication in the Official Gazette.

Existing regulations already set ethyl alcohol limits for traditional medicine systems: Ayurvedic, Siddha, and Unani syrups can contain up to 16% alcohol, while homoeopathic medicines are limited to 12%. The latest amendment aims to create a uniform regulatory framework for all medicinal products with high alcohol content, ensuring they are supplied through regulated channels and reducing the risk of diversion and misuse while preserving their availability for genuine therapeutic use.

Latest in Health 10
Centre proposes easing medical device rules: sterilisation licence burden removed, EU added for faster approvals
health

Centre proposes easing medical device rules: sterilisation licence burden removed, EU added for faster approvals

The Union Health Ministry has proposed changes to the Medical Devices Rules, 2017, removing the need for a separate licence for outsourced sterilisation and adding the EU to the list of jurisdictions whose approvals can waive clinical investigation requirements in India. The steps aim to ease compliance and accelerate patient access to new medical technologies.

The Hindu 24 Aug 2026, 12:22 PM
Read More →
→ View All Health News